TNF and inflammatory bowel disease: Anti-tumor necrosis factor-α (TNF) therapy is a first-line biological drug for the treatment of moderate-to-severe inflammatory bowel disease, refractory to conventional therapy (mesalamine, steroids, and immunosuppressants) [65,66].